🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are urged to message these accounts directly for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where communities with numerous of participants share comparison images, injection guides and claims of next-day British shipping. Vendors promote the substance there before directing buyers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Experts Voice Concerns

However, physicians and pharmacists have warned that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could lead to individuals injecting substances of unknown origin.

Some professionals said the popularity for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, prosecution or prison.

Platform Reaction and Material Removal

Based on the social media company, the service has removed problematic content and prohibited associated keywords and query recommendations. The company said it was committed to maintaining the platform safe and allocating resources in enhancing enforcement strategies.

Digital Marketplace Activities

Research also found groups with up to nine thousand participants selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, populated with photos of weight loss, positive reviews and step-by-step instructions for preparing or administering at residence.

Within moments of entering one group, a seller shared WhatsApp details, where most purchases take place. The seller sent an instruction manual and promised shipping within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about weight, medical conditions or past usage.

Product Details and Costs

Within these groups, posts display dark colored packages with Royal Mail labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20mg. When questioned how much time a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service said it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting materials they can’t verify. Even if the research behind this drug is sound, these digital versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices rising, patients are using social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.

Her team has previously seen individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a company experimental substance not yet approved … may expose users to possibly serious medical dangers”.